Zydus Pharmaceuticals announced a voluntary recall of one lot of Warfarin 2mg Tablets because they have been found to be oversized in a product complaint. The affected product has Lot #MM5767 and ...

Zydus Receives Final Approval From The USFDA For Erythromycin Tablets Erythromycin Tablets USP, 250 mg and 500mg had annual sales of USD 23mn in the United States. FPJ Web Desk Updated: Friday ...

The FDA says that Zydus Pharmaceuticals is voluntarily recalling one lot of warfarin 2 mg tablets, after receiving one complaint that four oversized tablets had been discovered.

Zydus is among the first suppliers to launch the generic version of Mirabegron Extended-Release Tablets, USP 25 mg in the US market and is prepared to launch Mirabegron Extended-Release Tablets ...

Pharmaceuticals major Zydus Group on Wednesday announced receipt of approval to sell chronic pain reliever morphine sulfate tablets from the US Food and Drug Administration (USFDA).

Zydus was one of the first ANDA applicants to submit a substantially complete ANDA with a paragraph IV certification for Brivaracetam Tablets USP 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg.

Zydus being one of the first applicants for Roflumilast Tablets (500 mcg) is eligible for 180 days of shared generic drug exclusivity under section 505(j)(5)(B)(iv) of the FD&C Act.

Zydus was one of the first ANDA applicants to submit a substantially complete ANDA with a paragraph IV certification for Brexpiprazole tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg and ...